Skip to content
Homepage
Clinic directory

Clinics in El Paso, New Mexico

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

El Paso, NM

Stem Cell Therapy clinics in El Paso

El Paso supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Texas Tech University Health Sciences Center El Paso and The Hospitals of Providence, and stem cell practice in the area spans West Side, East Side, and the Medical Center of the Americas corridor. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. House Bill 810 (2017) permits licensed Texas physicians to administer investigational adult stem cell treatments for patients with severe chronic diseases or terminal illnesses under institutional review board oversight, without an FDA Investigational New Drug authorization. Texas Medical Board licensure is required, and advertising is regulated under the Texas Occupations Code. The 8 El Paso clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Texas Medical Board licensure checks.

1 Clinics

Agape Pain Management and Anesthesia

El Paso, NM

Agape Pain Management and Anesthesia, located in Las Cruces, specializes in regenerative orthobiologics and integrative pain management. The clinic offers platelet-rich plasma therapy and stem-cell i…

  • PRP Therapy
  • Ketamine Therapy
  • Arthritis Treatment
  • Migraine Treatment
  • Stem Cell Therapy
15 30 50 results per page

Regulatory context

A note on New Mexico's stem cell therapy rules.

New Mexico cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in New Mexico for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. New Mexico's regulatory environment relies on federal law and the Medical Practice Act.

  • New Mexico Medical Practice Act, NMSA Chapter 61, Article 6
    Establishes physician licensure and discipline through the New Mexico Medical Board.
  • New Mexico Naturopathic Doctor Practice Act
    Provides registration for naturopathic doctors with limited scope; cellular biologic injections are generally outside formulary.
  • New Mexico Pharmacy Act, NMSA Chapter 61, Article 11
    Regulates compounding pharmacies aligned with federal 503A and 503B standards.

The FDA has corresponded with New Mexico providers offering cellular therapies. The New Mexico Medical Board has authority to discipline physicians for unprofessional conduct including misleading regenerative medicine advertising. The New Mexico Attorney General can pursue deceptive marketing under the New Mexico Unfair Practices Act. New Mexico's smaller market means enforcement is less frequent than in larger states, but federal warning letters apply nationally.

Stem Cell Therapy in El Paso, answered.

Most stem cell therapies at private El Paso clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. House Bill 810 (2017) permits licensed Texas physicians to administer investigational adult stem cell treatments for patients with severe chronic diseases or terminal illnesses under institutional review board oversight, without an FDA Investigational New Drug authorization.

In the El Paso metro, single-joint autologous bone marrow or adipose injections typically run $4,000 to $12,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $8,000 to $20,000, and full multi-session protocols can reach $15,000 to $40,000. Exosome add-ons range $3,500 to $7,500. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. El Paso clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Texas Tech University Health Sciences Center El Paso and The Hospitals of Providence periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by El Paso or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the Texas Medical Board and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with HB 810.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology